Identification, synthesis and characterization of process related desfluoro impurity of ezetimibe an

来源 :Journal of Pharmaceutical Analysis | 被引量 : 0次 | 上传用户:ooo2231
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Ezetimibe, which selectively inhibits cholesterol absorption across the intestinal wall and is used as an antihyperlipidemic agent, is synthesized for commercial use as a drug substance in highly pure form.During the synthetic process development studies of ezetimibe, an impurity was detected in the final product at levels ranging from 0.05% to 0.15% in reverse phase gradient high performance liquid chromatography(HPLC) method and its molecular weight was determined by LC–MS analysis. The impurity was identified as(3R,4S)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-1-phenylazetidin-2-one which is called desfluoro ezetimibe(lactam-related) impurity, synthesized and characterized, the mechanism of its formation was discussed in detail. After all standardization procedures, it was used as a reference standard during validation of HPLC method and routine analyses. In addition,content of Eze-1 desfluoro impurity in Eze-1 intermediates was specified as 0.10% to keep the formation of desfluoro ezetimibe impurity under control and the related substances HPLC method was validated accordingly. Ezetimibe, which selectively inhibits cholesterol absorption across the intestinal wall and is used as an antihyperlipidemic agent, is synthesized for commercial use as a drug substance in highly pure form. During the synthetic process development studies of ezetimibe, an impurity was detected in the final product At levels ranging from 0.05% to 0.15% in reverse phase gradient high performance liquid chromatography (HPLC) method and its molecular weight was determined by LC-MS analysis. The impurity was identified as (3R, 4S) -3- -3- (4-fluorophenyl) -3-hydroxypropyl) -4- (4-hydroxyphenyl) -1 -phenylazetidin-2-one which is called desfluoro ezetimibe (lactam-related) impurity, synthesized and characterized, the mechanism of its formation After all standardization procedures, it was used as a reference standard during validation of HPLC method and routine analyzes. In addition, the content of Eze-1 desfluoro impurity in Eze-1 intermediates was specified as 0.10% to keep the formation of desfluoro ezetimibe impurity under control and the related substances HPLC method was validated accordingly.
其他文献
目的 分析心理护理干预在老年糖尿病患者康复治疗中的应用效果.方法 选取我院收治的老年糖尿病患者90例作为本次的观察对象,选取时间为2018年3月至2018年12月间,将其按照不同
目的:了解基层医院的医护人员对临床药学工作和临床药师的认知情况,为进一步开展基层医院临床药学服务提供参考.方法:设计调查问卷,对4所基层医院的625名医护人员进行实地问
先天性泪道瘘管的发病机制目前尚未明确,可能是由胚胎发育异常、遗传因素等多种因素作用的结果。每2 000名新生儿大约有1名发生该病。先天性泪道瘘管患者若不伴感染则自觉症状多不明显;若伴感染则会出现流泪、瘘口流脓和内眦部红肿痛等表现。先天性泪道瘘管的诊断和治疗引起了眼科医生的关注,并取得了较大研究进展。本文主要综述了先天性泪道瘘管的流行病学特点、发病机制、临床表现、检查、诊断、鉴别诊断及手术治疗等相关
本文中急性呼吸道感染是指急性上呼吸道感染、急性支气管炎、支气管肺炎,是感染性疾病中最常见的.1998年6月至1997年7月,笔者采用哈尔滨三联制药有限公司生产的注射用穿琥宁
目的探讨精细化护理管理在复发性急性胰腺炎(RAP)患者随访中的应用效果。方法收集2016年1月至2017年1月间海军军医大学附属长海医院收治的RAP患者的临床资料。采用自身对照的方法建立前瞻性队列研究,采取精细化护理管理模式对患者随访12个月,通过调查问卷收集患者遵医行为、疾病改善情况、患者满意度等指标以评估精细化护理管理的效果,每3个月1次,满12个月汇总。结果最终纳入64例RAP患者,平均随访
AIM: To study the effect of fluoride on oxidativestress,DNA damage and apoptosis as well as cell cycle of rat oral mucosal cells and hepatocytes.METHODS: Ten ma
期刊
目的 分析护理干预对甲亢患者生活质量及负性情绪的影响.方法 选取我院2018年1月至2019年1月接诊的甲亢患者70例作为本次研究对象,按照入院的先后顺序分成护理组和对照组,每